EPO Patent Bulletin: WT1 Peptides for Preventing Polyposis
Summary
The European Patent Office has published patent application EP3865146A1 concerning WT1 peptides and analogs for preventing or treating familial adenomatous polyposis and non-hereditary colorectal adenoma. The application lists the International Institute of Cancer Immunology, Inc. as the applicant.
What changed
This document is a publication from the European Patent Office (EPO) Bulletin detailing patent application EP3865146A1, titled "WT1 PEPTIDES AND ANALOGS THEREOF FOR PREVENTING OR TREATING FAMILIAL ADENOMATOUS POLYPOSIS AND NON-HEREDITARY COLORECTAL ADENOMA". The publication date is March 11, 2026, and the applicant is the International Institute of Cancer Immunology, Inc.
As this is a patent publication, it does not impose direct regulatory obligations or compliance deadlines on regulated entities. However, it signifies potential future developments in therapeutic treatments for polyposis and colorectal adenoma, which may be of interest to pharmaceutical companies and healthcare providers involved in research, development, and clinical applications in oncology.
Source document (simplified)
WT1 PEPTIDES AND ANALOGS THEREOF FOR PREVENTING OR TREATING FAMILIAL ADENOMATOUS POLYPOSIS AND NON-HEREDITARY COLORECTAL ADENOMA
Publication EP3865146A1 Kind: A1 Mar 11, 2026
Applicants
International Institute of Cancer Immunology, Inc.
Inventors
SUGIYAMA Haruo
IPC Classifications
A61K 38/04 20060101AFI20220520BHEP A61K 39/39 20060101ALI20220520BHEP A61K 48/00 20060101ALI20220520BHEP A61P 35/00 20060101ALI20220520BHEP C07K 14/82 20060101ALI20220520BHEP C12N 5/0783 20100101ALI20220520BHEP C12N 5/10 20060101ALI20220520BHEP C12N 15/12 20060101ALI20220520BHEP A61K 38/08 20190101ALI20220520BHEP A61K 38/10 20060101ALI20220520BHEP A61K 38/17 20060101ALI20220520BHEP A61K 39/00 20060101ALI20220520BHEP C07K 14/47 20060101ALI20220520BHEP C12N 5/09 20100101ALI20220520BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Named provisions
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: EPO Bulletin - Peptides (C07K) publishes new changes.